aleve

Generic: naproxen sodium

Labeler: r j general corporation
NDC Directory HUMAN OTC DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name aleve
Generic Name naproxen sodium
Labeler r j general corporation
Dosage Form TABLET
Routes
ORAL
Active Ingredients

naproxen sodium 220 mg/1

Manufacturer
R J General Corporation

Identifiers & Regulatory

Product NDC 70264-011
Product ID 70264-011_43c866a6-dc20-5e19-e063-6294a90aac20
Product Type HUMAN OTC DRUG
Marketing Category NDA
Application Number NDA020204
Listing Expiration 2026-12-31
Marketing Start 2014-02-26

Pharmacologic Class

Classes
anti-inflammatory agents non-steroidal [cs] cyclooxygenase inhibitors [moa] nonsteroidal anti-inflammatory drug [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70264011
Hyphenated Format 70264-011

Supplemental Identifiers

RxCUI
849574 849728
UNII
9TN87S3A3C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aleve (source: ndc)
Generic Name naproxen sodium (source: ndc)
Application Number NDA020204 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 220 mg/1
source: ndc
Packaging
  • 50 POUCH in 1 CARTON (70264-011-01) / 1 TABLET in 1 POUCH
source: ndc

Packages (1)

70264-011-01 50 POUCH in 1 CARTON (70264-011-01) / 1 TABLET in 1 POUCH

Ingredients (1)

naproxen sodium (220 mg/1)

Linked Drug Pages (1)

Aleve ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "43c866a6-dc20-5e19-e063-6294a90aac20", "openfda": {"unii": ["9TN87S3A3C"], "rxcui": ["849574", "849728"], "spl_set_id": ["46e7b298-9e19-49b6-be71-e4fdcb09a5d4"], "manufacturer_name": ["R J General Corporation"]}, "finished": true, "packaging": [{"sample": false, "description": "50 POUCH in 1 CARTON (70264-011-01)  / 1 TABLET in 1 POUCH", "package_ndc": "70264-011-01", "marketing_start_date": "20140226"}], "brand_name": "Aleve", "product_id": "70264-011_43c866a6-dc20-5e19-e063-6294a90aac20", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "70264-011", "generic_name": "NAPROXEN SODIUM", "labeler_name": "R J General Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aleve", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "NDA020204", "marketing_category": "NDA", "marketing_start_date": "20140226", "listing_expiration_date": "20261231"}